BeOne Medicines AG (FRA:49BA)

BeOne Medicines AG Statistics

Total Valuation

FRA:49BA has a market cap or net worth of EUR 31.95 billion. The enterprise value is 29.43 billion.

Market Cap	31.95B
Enterprise Value	29.43B

Important Dates

The next estimated earnings date is Friday, March 27, 2026.

Earnings Date	Mar 27, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+7.37%
Shares Change (QoQ)	+4.39%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	67.92M

Valuation Ratios

The trailing PE ratio is 1,135.81 and the forward PE ratio is 75.25.

PE Ratio	1,135.81
Forward PE	75.25
PS Ratio	7.50
PB Ratio	9.10
P/TBV Ratio	9.50
P/FCF Ratio	76.51
P/OCF Ratio	52.10
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 89.29, with an EV/FCF ratio of 70.49.

EV / Earnings	1,046.42
EV / Sales	6.84
EV / EBITDA	89.29
EV / EBIT	194.92
EV / FCF	70.49

Financial Position

The company has a current ratio of 2.40, with a Debt / Equity ratio of 0.28.

Current Ratio	2.40
Quick Ratio	2.11
Debt / Equity	0.28
Debt / EBITDA	2.97
Debt / FCF	2.38
Interest Coverage	12.61

Financial Efficiency

Return on equity (ROE) is 0.88% and return on invested capital (ROIC) is 2.39%.

Return on Equity (ROE)	0.88%
Return on Assets (ROA)	1.74%
Return on Invested Capital (ROIC)	2.39%
Return on Capital Employed (ROCE)	3.54%
Revenue Per Employee	387,292
Profits Per Employee	2,557
Employee Count	11,000
Asset Turnover	0.75
Inventory Turnover	1.43

Taxes

In the past 12 months, FRA:49BA has paid 110.75 million in taxes.

Income Tax	110.75M
Effective Tax Rate	79.75%

Stock Price Statistics

The stock price has increased by +52.58% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+52.58%
50-Day Moving Average	284.56
200-Day Moving Average	247.70
Relative Strength Index (RSI)	52.85
Average Volume (20 Days)	17

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:49BA had revenue of EUR 4.26 billion and earned 28.13 million in profits. Earnings per share was 0.25.

Revenue	4.26B
Gross Profit	3.68B
Operating Income	158.36M
Pretax Income	138.88M
Net Income	28.13M
EBITDA	284.54M
EBIT	158.36M
Earnings Per Share (EPS)	0.25

Balance Sheet

The company has 3.49 billion in cash and 995.55 million in debt, giving a net cash position of 2.49 billion.

Cash & Cash Equivalents	3.49B
Total Debt	995.55M
Net Cash	2.49B
Net Cash Per Share	n/a
Equity (Book Value)	3.51B
Book Value Per Share	31.75
Working Capital	2.80B

Cash Flow

In the last 12 months, operating cash flow was 613.18 million and capital expenditures -195.63 million, giving a free cash flow of 417.55 million.

Operating Cash Flow	613.18M
Capital Expenditures	-195.63M
Free Cash Flow	417.55M
FCF Per Share	n/a

Margins

Gross margin is 86.29%, with operating and profit margins of 3.72% and 0.66%.

Gross Margin	86.29%
Operating Margin	3.72%
Pretax Margin	3.26%
Profit Margin	0.66%
EBITDA Margin	6.68%
EBIT Margin	3.72%
FCF Margin	9.80%

Dividends & Yields

FRA:49BA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	72.48%
Buyback Yield	-7.37%
Shareholder Yield	-7.37%
Earnings Yield	0.09%
FCF Yield	1.31%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	8